BioCentury
ARTICLE | Company News

Biofrontera acquires dermatology compound

September 13, 2005 12:31 AM UTC

Biofrontera (Leverkusen, Germany) acquired from Switch (Neuried, Germany) an undisclosed compound to treat dermatological indications. Biofrontera, which will develop the compound for atopic dermatiti...